Novavax stockholders elect directors, approve advisory compensation, ratify auditor at 2025 annual meeting

NOVAVAX INC

Elected Class III directors Rachel K. King, John W. Shiver, and Charles W. Newton (each with majority 'For' votes).
Advisory vote on named executive officer compensation approved: 41,390,651 For, 15,830,308 Against.
Ratification of Ernst & Young as auditor for FY2025 approved: 79,306,893 For, 15,057,873 Against.
Quorum of 95,359,194 shares present; total outstanding shares were 161,968,503 as of record date April 21, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.